Notification Letter and Change Request Form to Registered Shareholder
Filed with HKEX · Stock code 460 · · 2 pages · English and Chinese
Summary by 6ix AI
This filing is a notification letter from Sihuan Pharmaceutical Holdings Group Ltd. regarding the publication of its interim report for a specific period. It informs shareholders about the availability of both English and Chinese versions of the report on the company's website and the HKEx news website. Additionally, it includes a change request form for shareholders to modify their preferences for receiving corporate communications.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sihuan Pharmaceutical Holdings Group Ltd. on 6ix
Earlier from Sihuan Pharmaceutical
- Interim Report 2026
- Voluntary announcement - insulin aspart 30 injection developed by Sihuan Pharmaceutical achieved equivalent clinical results in efficacy and safety study as originator drug
- Voluntary announcement-entering into strategic cooperation agreement between jilin huisheng biopharmaceutical and porton pharma
- Voluntary announcement - share repurchase
- Voluntary announcement-Sihuan Pharmaceutical obtained drug registration approval in relation to ambroxol hydrochloride injection
Later from Sihuan Pharmaceutical
- Notification Letter and Request Form to Non-registered Holder
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement - new specifications of skin booster (brand name: dongyan) of Sihuan Pharmaceutical approved for launch by nmpa
- Voluntary announcement-Sihuan Pharmaceutical completed a strategic investment in canton biologics to enhance the layout of the entire industrial chain of regenerative medical aesthetics
- Voluntary announcement - polycaprolactone microsphere facial filler for Injection and hyaluronic acid sodium composite solution for Injection independently developed by meiyan space, a subsidiary of Sihuan Pharmaceutical, approved for market launch in hong kong
Follow Sihuan Pharmaceutical into a list and get an email when it puts out news.
Follow Sihuan Pharmaceutical